Assessing immune responses to pneumococcal vaccines
Open Access
- 1 July 2003
- journal article
- letter
- Published by BMJ in Archives of Disease in Childhood
- Vol. 88 (7) , 648-649
- https://doi.org/10.1136/adc.88.7.648
Abstract
The recent article and letter1,2 discussing recommendations for use of heptavalent pneumococcal conjugate vaccine (Prevenar) for at risk children is timely and interesting. We concur with the authors that further immunogenicity studies are necessary in various high risk groups to demonstrate the best protective schedule. Children older than 2 years with recurrent infections and normal humoral immunity assessed by serum immunoglobulin levels and specific antibody responses to protein antigens, but repeated …Keywords
This publication has 2 references indexed in Scilit:
- On Archimedes * Author's replyArchives of Disease in Childhood, 2003
- Should the new pneumococcal vaccine be used in high-risk children?Archives of Disease in Childhood, 2002